Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients
NCT00110552 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2014-10-29
Summary
The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease.
Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.
Conditions
- Alzheimer Disease
Interventions
- DRUG
-
Salvia officinalis (sage)
oral dosage
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Oregon Health and Science University
lead OTHER
Principal Investigators
-
Barry Oken, MD · Oregon Health and Science University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease
NCT05578443 ·Status: RECRUITING ·Phase: PHASE2
-
Salsalate in Patients Mild to Moderate Alzheimer's Disease
NCT03277573 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
NCT04213391 ·Status: UNKNOWN ·Phase: NA
-
Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease
NCT06694597 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.
NCT04522960 ·Status: UNKNOWN ·Phase: NA
-
Huperzine A in Alzheimer's Disease
NCT00083590 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment
NCT02982603 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease
NCT03038334 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT04602624 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction
NCT01554475 ·Status: COMPLETED
-
Improving Sleep and Cognition in Alzheimer's Disease
NCT05200208 ·Status: COMPLETED ·Phase: NA
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Cognizin Citicoline Dosing in a Healthy Adolescent Male Population
NCT01582113 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease
NCT01453569 ·Status: COMPLETED ·Phase: PHASE2
-
Galantamine Effects on Cognitive Function in Marijuana Users
NCT00969696 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
NCT00544791 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
NCT05307692 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
Zydena on Cognitive Function of Alzheimer's Disease Patients
NCT01940952 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults
NCT02181972 ·Status: COMPLETED ·Phase: PHASE3
-
Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase
NCT07091747 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
NCT01354691 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of HellenCare in Early-Stage Alzheimer's Disease
NCT06895525 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
NCT02260167 ·Status: COMPLETED ·Phase: NA